Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1330 |
---|---|
Product Name | Anti-Human CD51 Recombinant Antibody |
Molecular Name | Abituzumab |
Alias | Anti-CD51 Recombinant Antibody, Research Grade Abituzumab |
CAS Number | 1105038-73-0 |
Target | CD51[Homo sapiens] |
Isotype | IgG2 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Inhib, Agonist |
Buffer | PBS, pH7.5 |
Background | Abituzumab is a humanized IgG2 monoclonal antibody (mAb) targeted at CD51 (an integrin) currently in development by Merck KGaA Darmstadt, Germany in an attempt to prevent bone lesion metastases in castration-resistant prostate cancer. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |